Dr Eric Stephen Striepeck, OD | |
130 Black Horse Pike Ste D-4, Audubon, NJ 08106-1960 | |
(856) 672-3326 | |
Not Available |
Full Name | Dr Eric Stephen Striepeck |
---|---|
Gender | Male |
Speciality | Optometrist |
Location | 130 Black Horse Pike Ste D-4, Audubon, New Jersey |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1194031625 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | 27OA00627200 (New Jersey) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Eric Stephen Striepeck, OD 1 Franklin Town Blvd Apt 418, Philadelphia, PA 19103-1242 Ph: (570) 881-5401 | Dr Eric Stephen Striepeck, OD 130 Black Horse Pike Ste D-4, Audubon, NJ 08106-1960 Ph: (856) 672-3326 |
News Archive
Imagine you have a bone fracture or a hip replacement, and you need bone to form, but you heal slowly - a common fact of life for older people. Instead of forming bone, you could form fat. Researchers at the University of North Carolina School of Medicine may have found a way to tip the scale in favor of bone formation. They used cytochalasin D, a naturally occurring substance found in mold, as a proxy to alter gene expression in the nuclei of mesenchymal stem cells to force them to become osteoblasts (bone cells).
Short pieces of RNA, known as small interfering RNA (siRNA), have the potential to become a new class of anticancer drugs if researchers can solve the problem of how to deliver these fragile molecules to cancer cells.
Although a class schedule with later start times allows colleges students to get more sleep, it also gives them more time to stay out drinking at night. As a result, their grades are more likely to suffer, suggests a research abstract that will be presented Tuesday, June 14, in Minneapolis, Minn., at SLEEP 2011, the 25th Anniversary Meeting of the Associated Professional Sleep Societies LLC.
Salix Pharmaceuticals, Ltd. and Alfa Wassermann S.p.A. today announced that they have entered into an exclusive agreement by which Salix has licensed rights in the United States and Canada to an extended intestinal release (EIR) formulation of rifaximin for gastrointestinal and respiratory indications, including Crohn's disease.
› Verified 8 days ago
Eun-young Esther Ko, OD, MPH Optometrist Medicare: Not Enrolled in Medicare Practice Location: 130 Black Horse Pike Ste D-4, Audubon, NJ 08106 Phone: 856-672-3326 |